Validation of the Spanish Version of the Trauma and Loss Spectrum Self-Report (TALS-SR): A Study on Healthcare Workers Facing the COVID-19 Pandemic.
PTSD
health personnel
mental health
psychological distress
psychological tests
stress disorders
traumatic
Journal
Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
11
2022
accepted:
17
12
2022
entrez:
10
3
2023
pubmed:
11
3
2023
medline:
11
3
2023
Statut:
epublish
Résumé
The present study aimed at reporting about the validity and reliability of the Spanish version of the Trauma and Loss Spectrum-Self Report (TALS-SR), an instrument based on a multidimensional approach to Post-Traumatic Stress Disorder (PTSD) and Prolonged Grief Disorder (PGD), including a range of threatening or traumatic experiences and significant losses, besides the spectrum of peri-traumatic stress reactions and post-traumatic stress symptoms that may occur. A sample of 87 Health Care Workers (HCWs) employed in the COVID-19 Emergency Department at the Virgen de la Arrixaca and Reina Sofia Hospitals (Murcia, Spain) during the pandemic, was consecutively recruited and fulfilled the TALS-SR. Assessments also included the Impact of Event Scale-Revised (IES-R), to examine post-traumatic stress symptoms and probable PTSD. Nineteen HCWs fulfilled the TALS-SR again after three weeks from baseline for test-retest reliability. This study provides evidence of good internal consistency and test-retest reliability of the Spanish version of the TALS-SR. Strong support for the internal validity structure was obtained, with positive and significant correlations between the five symptomatologic domains and the symptomatologic total score. Significant and good correlations between the TALS-SR symptomatologic domains and the IES-R total and single domains' scores were found. The Questionnaire also demonstrated to discriminate between subjects with and without PTSD, with subjects with PTSD showing significantly higher mean scores in each domain of the TALS-SR. This study validates the Spanish version of TALS-SR, providing a useful instrument for a spectrum approach to PTSD and confirms the potential utility of this psychometric tool in both clinical practice and research settings.
Sections du résumé
Background
UNASSIGNED
The present study aimed at reporting about the validity and reliability of the Spanish version of the Trauma and Loss Spectrum-Self Report (TALS-SR), an instrument based on a multidimensional approach to Post-Traumatic Stress Disorder (PTSD) and Prolonged Grief Disorder (PGD), including a range of threatening or traumatic experiences and significant losses, besides the spectrum of peri-traumatic stress reactions and post-traumatic stress symptoms that may occur.
Methods
UNASSIGNED
A sample of 87 Health Care Workers (HCWs) employed in the COVID-19 Emergency Department at the Virgen de la Arrixaca and Reina Sofia Hospitals (Murcia, Spain) during the pandemic, was consecutively recruited and fulfilled the TALS-SR. Assessments also included the Impact of Event Scale-Revised (IES-R), to examine post-traumatic stress symptoms and probable PTSD. Nineteen HCWs fulfilled the TALS-SR again after three weeks from baseline for test-retest reliability.
Results
UNASSIGNED
This study provides evidence of good internal consistency and test-retest reliability of the Spanish version of the TALS-SR. Strong support for the internal validity structure was obtained, with positive and significant correlations between the five symptomatologic domains and the symptomatologic total score. Significant and good correlations between the TALS-SR symptomatologic domains and the IES-R total and single domains' scores were found. The Questionnaire also demonstrated to discriminate between subjects with and without PTSD, with subjects with PTSD showing significantly higher mean scores in each domain of the TALS-SR.
Conclusion
UNASSIGNED
This study validates the Spanish version of TALS-SR, providing a useful instrument for a spectrum approach to PTSD and confirms the potential utility of this psychometric tool in both clinical practice and research settings.
Identifiants
pubmed: 36896340
doi: 10.2147/NDT.S396540
pii: 396540
pmc: PMC9990502
doi:
Types de publication
Journal Article
Langues
eng
Pagination
495-506Informations de copyright
© 2023 Carmassi et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest in this work.
Références
Int J Environ Res Public Health. 2021 Jan 12;18(2):
pubmed: 33445712
Psychiatr Serv. 2008 Jan;59(1):91-5
pubmed: 18182545
CNS Spectr. 2020 Jul 14;:1-2
pubmed: 32660685
Am J Psychiatry. 2013 Jan;170(1):1-5
pubmed: 23288382
Neuropsychiatr Dis Treat. 2021 May 07;17:1375-1384
pubmed: 33994787
Psychiatry Res. 2020 Oct;292:113312
pubmed: 32717711
Neuropsychiatr Dis Treat. 2022 Apr 05;18:761-771
pubmed: 35414744
Int J Environ Res Public Health. 2022 Mar 28;19(7):
pubmed: 35409690
Front Psychiatry. 2020 Nov 16;11:492006
pubmed: 33304278
Cochrane Database Syst Rev. 2020 Nov 5;11:CD013779
pubmed: 33150970
Neuropsychiatr Dis Treat. 2018 May 25;14:1371-1379
pubmed: 29872304
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Front Psychiatry. 2021 Apr 26;12:646385
pubmed: 33981258
J Psychiatr Pract. 2013 Sep;19(5):419-28
pubmed: 24042249
Neuropsychiatr Dis Treat. 2021 Aug 28;17:2831-2840
pubmed: 35497932
J Trauma Stress. 2005 Oct;18(5):485-9
pubmed: 16281246
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
Compr Psychiatry. 2014 Feb;55(2):357-62
pubmed: 24269194
Eur Psychiatry. 2022 Jan 21;65(1):e10
pubmed: 35060458
Int J Environ Res Public Health. 2020 Aug 26;17(17):
pubmed: 32858810
J Psychiatr Res. 2021 Apr;136:14-22
pubmed: 33548826
J Rehabil Res Dev. 2012;49(5):649-65
pubmed: 23015577
Riv Psichiatr. 2021 Jul-Aug;56(4):189-197
pubmed: 34310576
Case Rep Psychiatry. 2019 May 26;2019:4703795
pubmed: 31249714
Intensive Crit Care Nurs. 2022 Apr;69:103154
pubmed: 34895972
CNS Spectr. 2009 May;14(5):262-6
pubmed: 19407725
PLoS One. 2021 Nov 10;16(11):e0258893
pubmed: 34758047
J Psychiatr Res. 2020 Oct;129:141-146
pubmed: 32912594
Clin Pract Epidemiol Ment Health. 2008 Jan 28;4:2
pubmed: 18226228
Psychiatry Res. 2012 Aug 15;198(3):436-40
pubmed: 22436352
Neuropsychiatr Dis Treat. 2020 Oct 28;16:2529-2537
pubmed: 33149594
Drug Alcohol Depend. 2013 Feb 1;128(1-2):45-51
pubmed: 22917752
BMC Public Health. 2012 May 15;12:249
pubmed: 22455604
Psychiatry Res. 2021 Apr;298:113763
pubmed: 33545425
Compr Psychiatry. 2009 Sep-Oct;50(5):485-90
pubmed: 19683620
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823
Ann Gen Psychiatry. 2014 Nov 18;13:28
pubmed: 25670961
Front Psychiatry. 2021 May 31;12:658846
pubmed: 34135784
Front Psychiatry. 2020 Jun 05;11:533
pubmed: 32581895
World Psychiatry. 2022 Jun;21(2):310-311
pubmed: 35524624
Neuropsychiatr Dis Treat. 2021 May 06;17:1363-1373
pubmed: 33986596
Front Psychiatry. 2021 Nov 15;12:764738
pubmed: 34867550